BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/27/2024 11:58:45 AM | Browse: 436 | Download: 1251
Publication Name World Journal of Hepatology
Manuscript ID 90434
Country United States
ISSN 1948-5182 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Editorial
Article Title Interleukins in liver disease treatment
Manuscript Source Invited Manuscript
All Author List Ming Yang and Chun-Ye Zhang
ORCID
Author(s) ORCID Number
Ming Yang http://orcid.org/0000-0002-4895-5864
Chun-Ye Zhang http://orcid.org/0000-0003-2567-029X
Funding Agency and Grant Number
Corresponding Author Ming Yang, DVM, PhD, Research Assistant Professor, Department of Surgery, University of Missouri, Room 2203, NextGen Precision Building, 1030 Hitt Street, Columbia, MO 65212, United States. yangmin@health.missouri.edu
Key Words Interleukins; Family members; Liver disease; Treatment; Clinical trials
Core Tip Interleukins as a large group of cytokines play pleiotropic roles in liver homeostasis and disease by regulating both innate and adaptive immune responses. They can be divided into seven families, and all of them are involved in the pathogenesis and resolution of chronic liver diseases. Currently, interleukin-mediated therapies are applied in patients with hepatitis induced by alcohol or hepatitis virus infection.
Publish Date 2024-02-27 11:58
Citation Yang M, Zhang CY. Interleukins in liver disease treatment. World J Hepatol 2024; 16(2): 140-145
URL https://www.wjgnet.com/1948-5182/full/v16/i2/140.htm
DOI https://dx.doi.org/10.4254/wjh.v16.i2.140
Full Article (PDF) WJH-16-140-with-cover.pdf
Full Article (Word) WJH-16-140.docx